SLC5A1 and Insulin resistance: Furthermore, we proved the intermediary role of insulin resistance on the association between SGLT1 inhibition and frailty, suggesting that the attenuation of frailty by SGLT1 inhibition was possibly mediated by the alleviation of insulin resistance.